Anti-Inflammatory Drugs Market Report 2026

Anti-Inflammatory Drugs Market Overview

• Anti-Inflammatory Drugs market size has reached to $152.08 billion in 2025 • Expected to grow to $252.87 billion in 2030 at a compound annual growth rate (CAGR) of 10.6% • Growth Driver: The Rising Prevalence Of Arthritis Is Fueling The Market Growth Due To Increasing Aging Populations And Musculoskeletal Conditions • Market Trend: Advancement in Next-Generation Anti-Inflammatory Therapeutics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anti-Inflammatory Drugs Market?

Anti-inflammatory drugs are a class of medications that reduce inflammation, pain, fever, and swelling by interfering with the body’s natural inflammatory response. These drugs work by inhibiting the action or production of chemical messengers such as prostaglandins, leukotrienes, and cytokines, which are involved in triggering and sustaining inflammation. The main drug classes of anti-inflammatory drugs are steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), biologics and biosimilars, and others. Steroids are anti-inflammatory medications that mimic natural hormones and are used to treat conditions such as asthma, arthritis, and allergies. They can be administered through various routes, including parenteral, oral, topical, and inhalation. These drugs are used for a range of applications, such as autoimmune diseases, respiratory diseases, and other conditions. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Anti-Inflammatory Drugs Market Growth Forecast?

The anti-inflammatory drugs market size is expected to see rapid growth in the next few years. It will grow to $252.87 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to biologic innovation, biosimilar penetration, aging population, autoimmune disease growth, precision medicine adoption. Major trends in the forecast period include growing use of biologics and biosimilars, expansion of chronic inflammatory disease treatment, shift toward targeted anti-inflammatory therapies, growth of topical and localized formulations, increased focus on long-term safety.

Global Anti-Inflammatory Drugs Market Segmentation

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes 2) By Route of Administration: Parenteral, Oral, Topical, Inhalation 3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases 4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments: 1) By Steroids: Corticosteroids, Mineralocorticoids 2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors 3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars 4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

What Is The Driver Of The Anti-Inflammatory Drugs Market?

The rising prevalence of arthritis is expected to propel the growth of the anti-inflammatory drugs market going forward. Arthritis refers to the inflammation of one or more joints, causing pain, swelling, and stiffness that can worsen with age. The rising prevalence of arthritis is primarily due to aging populations as people grow older, the natural wear and tear on joints increases, resulting to a higher likelihood of developing arthritis. Anti-inflammatory drugs help manage arthritis by reducing joint inflammation and pain, allowing patients to maintain better mobility and perform daily activities with greater ease, ultimately improving their overall quality of life. For instance, in July 2024, according to Restored CDC, a US-based nonprofit health information body, an estimated 21.2% of adults aged 18 and older in the US were diagnosed with arthritis in 2023. Therefore, the rising prevalence of arthritis is driving the growth of the anti-inflammatory drugs industry.

Key Players In The Global Anti-Inflammatory Drugs Market

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Global Anti-Inflammatory Drugs Market Trends and Insights

Major companies operating in the anti-inflammatory drugs market are focusing on developing innovative solutions, such as next-generation corticosteroid alternatives, to meet the rising demand for safer long-term anti-inflammatory therapies. A next-generation corticosteroid alternative is a therapy engineered to retain glucocorticoid anti-inflammatory effects while reducing adverse outcomes commonly associated with traditional steroids, including bone loss, growth suppression, and weight gain. For instance, in October 2023, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, received US FDA approval for AGAMREE (vamorolone). AGAMREE is an oral dissociative steroid designed to deliver anti-inflammatory activity with reduced steroid-related side effects by selectively modulating glucocorticoid receptor pathways and stabilizing cell membranes. Compared to traditional corticosteroids like prednisone and deflazacort, it offers a more favorable safety profile while maintaining therapeutic benefits. It is used to manage chronic muscle inflammation in children aged two years and older with Duchenne muscular dystrophy.

What Are Latest Mergers And Acquisitions In The Anti-Inflammatory Drugs Market?

In October 2023, Amgen, a US-based biopharmaceutical company, acquired Horizon Therapeutics for approximately US$ 27.8 billion. Through this acquisition, Amgen aims to strengthen its portfolio in autoimmune and severe inflammatory diseases by integrating Horizon’s therapies, including TEPEZZA, KRYSTEXXA, and UPLIZNA, and expanding its presence in the treatment of rare and chronic inflammatory conditions. Horizon Therapeutics is an Ireland-based biopharmaceutical company specializing in therapies for rare inflammatory and autoimmune diseases.

Regional Insights

North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anti-Inflammatory Drugs Market?

The anti-inflammatory drugs market consists of sales of immunosuppressants, COX-2 inhibitors, interleukin inhibitors, and TNF-alpha inhibitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anti-Inflammatory Drugs Market Report 2026?

The anti-inflammatory drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anti-inflammatory drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.